Skip to content
Brand AI

G1 Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    FDA approves COSELA

    G1 Therapeutics announced that the U.S. Food and Drug Administration approved COSELA (trilaciclib) for injection to decrease chemotherapy-induced myelosuppression in certain adult patients with extensive-stage small cell lung cancer.

    Source